These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9915958)

  • 1. Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13.
    Lloyd SE; Pannett AA; Dixon PH; Whyte MP; Thakker RV
    Am J Hum Genet; 1999 Jan; 64(1):189-95. PubMed ID: 9915958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6 Mb containing four mouse calcium-sensing receptor-related sequences: relevance to familial benign hypocalciuric hypercalcaemia type 3.
    Hannan FM; Nesbit MA; Turner JJ; Stacey JM; Cianferotti L; Christie PT; Conigrave AD; Whyte MP; Thakker RV
    Eur J Hum Genet; 2010 Apr; 18(4):442-7. PubMed ID: 19809483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a second kindred with familial hypocalciuric hypercalcemia type 3 (FHH3) narrows localization to a <3.5 megabase pair region on chromosome 19q13.3.
    Nesbit MA; Hannan FM; Graham U; Whyte MP; Morrison PJ; Hunter SJ; Thakker RV
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1947-54. PubMed ID: 20133464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity.
    Heath H; Jackson CE; Otterud B; Leppert MF
    Am J Hum Genet; 1993 Jul; 53(1):193-200. PubMed ID: 8317484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH.
    Trump D; Whyte MP; Wooding C; Pang JT; Pearce SH; Kocher DB; Thakker RV
    Hum Genet; 1995 Aug; 96(2):183-7. PubMed ID: 7635467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders of the calcium-sensing receptor.
    Thakker RV
    Biochim Biophys Acta; 1998 Dec; 1448(2):166-70. PubMed ID: 9920407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diseases associated with the extracellular calcium-sensing receptor.
    Thakker RV
    Cell Calcium; 2004 Mar; 35(3):275-82. PubMed ID: 15200151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16.
    Janicic N; Soliman E; Pausova Z; Seldin MF; Rivière M; Szpirer J; Szpirer C; Hendy GN
    Mamm Genome; 1995 Nov; 6(11):798-801. PubMed ID: 8597637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.
    Heath H; Odelberg S; Jackson CE; Teh BT; Hayward N; Larsson C; Buist NR; Krapcho KJ; Hung BC; Capuano IV; Garrett JE; Leppert MF
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1312-7. PubMed ID: 8636323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
    J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
    D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor.
    Carling T; Szabo E; Bai M; Ridefelt P; Westin G; Gustavsson P; Trivedi S; Hellman P; Brown EM; Dahl N; Rastad J
    J Clin Endocrinol Metab; 2000 May; 85(5):2042-7. PubMed ID: 10843194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families.
    Schwarz P; Larsen NE; Lønborg Friis IM; Lillquist K; Brown EM; Gammeltoft S
    Scand J Clin Lab Invest; 2000 May; 60(3):221-7. PubMed ID: 10885494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.
    Hannan FM; Thakker RV
    Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):359-71. PubMed ID: 23856265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
    Falchetti A; Gozzini A; Terranegra A; Soldati L; Vezzoli G; Leoncini G; Giusti F; Franceschelli F; Masi L; Tanini A; Cavalli L; Brandi ML
    Eur J Endocrinol; 2012 May; 166(5):933-40. PubMed ID: 22315359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
    Pearce SH; Trump D; Wooding C; Besser GM; Chew SL; Grant DB; Heath DA; Hughes IA; Paterson CR; Whyte MP
    J Clin Invest; 1995 Dec; 96(6):2683-92. PubMed ID: 8675635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
    Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    D'Souza-Li L; Canaff L; Janicic N; Cole DE; Hendy GN
    Hum Mutat; 2001 Nov; 18(5):411-21. PubMed ID: 11668634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.